Format

Send to

Choose Destination
Nat Rev Clin Oncol. 2018 Oct 13. doi: 10.1038/s41571-018-0110-3. [Epub ahead of print]

The promise of ESCAT: a new system for evaluating cancer drug-target pairs.

Author information

1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. bg.bishalgyawali@gmail.com.
2
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
PMID:
30317250
DOI:
10.1038/s41571-018-0110-3

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center